{"id":55719,"date":"2023-04-12T11:04:27","date_gmt":"2023-04-12T09:04:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/"},"modified":"2023-04-12T11:04:27","modified_gmt":"2023-04-12T09:04:27","slug":"global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/","title":{"rendered":"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2229053\/global_central_nervous_system_partnering?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wzj5g7&amp;utm_campaign=1839043+-+Global+Central+Nervous+System+Partnering+2023%3A+Information+on+Every+Deal+Since+2016&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg\"><\/a><\/p>\n<p>\nGlobal Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2016.<\/p>\n<ul>\n<li>\nTrends in central nervous system partnering deals<\/li>\n<li>\nFinancial deal terms for headline, upfront and royalty by stage of development<\/li>\n<li>\nCentral Nervous System partnering agreement structure<\/li>\n<li>\nCentral Nervous System partnering contract documents<\/li>\n<li>\nTop central nervous system deals by value<\/li>\n<li>\nMost active central nervous system dealmakers<\/li>\n<\/ul>\n<p>\nMost of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor&#8217;s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&amp;D and a commercialization of outcomes element.<\/p>\n<p>\nThe report takes readers through the comprehensive central nervous system disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering central nervous system deals.<\/p>\n<p>\nThe report presents financial deal terms values for central nervous system deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.<\/p>\n<p>\nThe initial chapters of this report provide an orientation of central nervous system dealmaking trends.<\/p>\n<p>\nChapter 1 provides an introduction to the report.<\/p>\n<p>\nChapter 2 provides an overview of the trends in central nervous system dealmaking since 2016 covering trends by year, deal type, stage of development, technology type and therapeutic indication.<\/p>\n<p>\nChapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.<\/p>\n<p>\nChapter 4 provides a review of the leading central nervous system deals since 2016. Deals are listed by headline value. The chapter includes the top 25 most active central nervous system dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.<\/p>\n<p>\nChapter 5 provides comprehensive access to central nervous system deals since 2016 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.<\/p>\n<p>\nChapter 6 provides a comprehensive directory of all central nervous system partnering deals by specific central nervous system target announced since 2016. The chapter is organized by specific central nervous system therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.<\/p>\n<p>\nIn addition, a comprehensive appendix is provided with each report of all central nervous system partnering deals signed and announced since 2016. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&amp;D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.<\/p>\n<p>\nThe report also includes numerous tables and figures that illustrate the trends and activities in central nervous system partnering and dealmaking since 2016.<\/p>\n<p>\nIn conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of central nervous system technologies and products.<\/p>\n<p>\n<strong>Report scope<\/strong><\/p>\n<p>\nGlobal Central Nervous System Partnering 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to central nervous system trends and structure of deals entered into by leading companies worldwide.<\/p>\n<p>\n<strong>Global Central Nervous System Partnering 2016 to 2023 includes:<\/strong><\/p>\n<ul>\n<li>\nTrends in central nervous system dealmaking in the biopharma industry since 2016<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data<\/li>\n<li>\nAccess to hundreds of central nervous system deal contract documents<\/li>\n<li>\nComprehensive access to over 1,700 central nervous system deal records<\/li>\n<li>\nThe leading central nervous system deals by value since 2016<\/li>\n<li>\nMost active central nervous system dealmakers since 2016<\/li>\n<\/ul>\n<p>\nThe report includes deals for the following indications: Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis\/Lou Gehrig&#8217;s Disease, Multiple sclerosis, Nausea, Neuropathy, Pain, Neuralgia, Fibromyalgia, Paralysis, Parkinson&#8217;s disease, Restless leg syndrome, Spinal cord, Stroke, Stuttering, Traumatic Brain Injury, Vertigo, Weakness, plus other CNS indications.<\/p>\n<p>\n<strong>In Global Central Nervous System Partnering 2016 to 2023, available deals and contracts are listed by:<\/strong><\/p>\n<ul>\n<li>\nHeadline value<\/li>\n<li>\nUpfront payment value<\/li>\n<li>\nRoyalty rate value<\/li>\n<li>\nStage of development at signing<\/li>\n<li>\nDeal component type<\/li>\n<li>\nTechnology type<\/li>\n<li>\nSpecific therapy indication<\/li>\n<\/ul>\n<p>\nEach deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.<\/p>\n<p>\nThe Global Central Nervous System Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1,700 central nervous system deals.<\/p>\n<p>\n<strong>A Selection of Companies Mentioned<\/strong><\/p>\n<ul>\n<li>\n1ST Biotherapeutics<\/li>\n<li>\n2M<\/li>\n<li>\n3M Drug Delivery Systems<\/li>\n<li>\n3PrimeDx<\/li>\n<li>\n3SBio<\/li>\n<li>\n4SC Discovery<\/li>\n<li>\n7D Surgical<\/li>\n<li>\n23andMe<\/li>\n<li>\nA&amp;B Company<\/li>\n<li>\nA*STAR Agency for Science<\/li>\n<li>\nTechnology and Research<\/li>\n<li>\nAarhus University Hospital<\/li>\n<li>\nAbbott Laboratories<\/li>\n<li>\nAbbvie<\/li>\n<li>\nAbCellera<\/li>\n<li>\nAbeona Therapeutics<\/li>\n<li>\nAbide Therapeutics<\/li>\n<li>\nAblynx<\/li>\n<li>\nAb Medica<\/li>\n<li>\nAbzena<\/li>\n<li>\nACADIA Pharmaceuticals<\/li>\n<li>\nAccelerated Cure Project for MS<\/li>\n<li>\nAccelovance<\/li>\n<li>\nAccera Pharmaceuticals<\/li>\n<li>\nAcella Pharmaceuticals<\/li>\n<li>\nAcerus<\/li>\n<li>\nAcetylon Pharmaceuticals<\/li>\n<li>\nAC Immune<\/li>\n<li>\nAcorda Therapeutics<\/li>\n<li>\nActavis (acquired by Watson)<\/li>\n<li>\nActelion<\/li>\n<li>\nActicor Biotech<\/li>\n<li>\nActurum Life<\/li>\n<li>\nAcura Pharmaceuticals<\/li>\n<li>\nAcuraStem<\/li>\n<li>\nAdAlta<\/li>\n<li>\nAdamas Pharmaceuticals<\/li>\n<li>\nAdaptive Health<\/li>\n<li>\nAdare Pharmaceuticals<\/li>\n<li>\nAddex Therapeutics<\/li>\n<li>\nAdept Neuro<\/li>\n<li>\nAdvanced Cooling Therapy<\/li>\n<li>\nAdvanced Technologies Solutions<\/li>\n<li>\nAdvantage Consumer Healthcare<\/li>\n<li>\nAdventus Ventures<\/li>\n<li>\nAeon Bioscience<\/li>\n<li>\nAequus Pharmaceuticals<\/li>\n<li>\nAeromics<\/li>\n<li>\nAEterna Zentaris<\/li>\n<li>\nAethlon Medical<\/li>\n<li>\nAffilogic<\/li>\n<li>\nAFFiRiS<\/li>\n<li>\nAfraxis<\/li>\n<li>\nAFT Pharmaceuticals<\/li>\n<li>\nAgeX Therapeutics<\/li>\n<li>\nAgilent Technologies<\/li>\n<li>\nAgilis Biotherapeutics<\/li>\n<li>\nAguettant<\/li>\n<li>\nAiforia Technologies<\/li>\n<li>\nAiPing Pharmaceutical<\/li>\n<li>\nAirWare Labs<\/li>\n<li>\nAKC Canine Health Foundation<\/li>\n<li>\nAkorn<\/li>\n<li>\nAkrimax Pharmaceutical<\/li>\n<li>\nAlbany Molecular Research<\/li>\n<li>\nAlberta Health Services<\/li>\n<li>\nAlbert Einstein College of Medicine<\/li>\n<li>\nAlcyone Lifesciences<\/li>\n<li>\nAlder Biopharmaceuticals<\/li>\n<li>\nAlector<\/li>\n<li>\nAleva Neurotherapeutics<\/li>\n<li>\nAlexion Pharmaceuticals<\/li>\n<li>\nAlfa Wassermann<\/li>\n<li>\nAliveGen<\/li>\n<li>\nAlkahest<\/li>\n<li>\nAlkermes<\/li>\n<li>\nAllen Institute for Brain Science<\/li>\n<li>\nAllergan<\/li>\n<li>\nAllergan (name changed from Actavis)<\/li>\n<li>\nAllied Healthcare Products<\/li>\n<li>\nAlnylam Pharmaceuticals<\/li>\n<li>\nALS Association<\/li>\n<li>\nAlseres Pharmaceuticals<\/li>\n<li>\nALS Finding a Cure Foundation<\/li>\n<li>\nAltair<\/li>\n<li>\nAltus Formulation<\/li>\n<li>\nAlzeCure Pharma<\/li>\n<li>\nAlzheimer&#8217;s Association<\/li>\n<li>\nAlzheimer&#8217;s Drug Discovery Foundation<\/li>\n<li>\nAlzheimers Research UK<\/li>\n<li>\nAmarantus BioSciences<\/li>\n<li>\nAmbu<\/li>\n<li>\nAmedica<\/li>\n<li>\nAmendia<\/li>\n<li>\nAmerican Academy of Neurology<\/li>\n<li>\nAmerican Association of Neuromuscular &amp; Electrodiagnostic Medicine<\/li>\n<li>\nAmerican College of Emergency Physicians<\/li>\n<li>\nAmerican College of Physicians Foundation<\/li>\n<li>\nAmerican Heart\/Stroke Association<\/li>\n<li>\nAmerican Heart Association<\/li>\n<li>\nAmerican Migraine Foundation<\/li>\n<li>\nAmerican National Multiple Sclerosis Society<\/li>\n<li>\nAmerican Parkinson Diseases Association<\/li>\n<li>\nAmerican Speech-Language-Hearing Association<\/li>\n<li>\nAmgen<\/li>\n<li>\nAmicus Therapeutics<\/li>\n<li>\nAmneal Pharmaceuticals<\/li>\n<li>\nAmorChem<\/li>\n<li>\nAmydis Diagnostics<\/li>\n<li>\nAmylgen<\/li>\n<li>\nAnaBios<\/li>\n<li>\nAnalytical Testing Laboratory<\/li>\n<li>\nAnavex Life Sciences<\/li>\n<li>\nANI Pharmaceuticals<\/li>\n<li>\nAnnette Funicello Research Fund for Neurological Diseases (AFRFND)<\/li>\n<li>\nAnnovis Bio<\/li>\n<li>\nAnthroTronix<\/li>\n<li>\nAntibe Therapeutics<\/li>\n<li>\nAntidote<\/li>\n<li>\nAphios<\/li>\n<li>\nApiFix<\/li>\n<li>\nAppello Pharmaceuticals<\/li>\n<li>\nAppliedVR<\/li>\n<li>\nAPR Applied Pharma Research<\/li>\n<li>\nAPRINOIA Therapeutics<\/li>\n<li>\nAptahem<\/li>\n<li>\nAptinyx<\/li>\n<li>\nAquinnah Pharmaceuticals<\/li>\n<li>\nAralez Pharmaceuticals<\/li>\n<li>\nAratana Therapeutics<\/li>\n<li>\narGEN-X<\/li>\n<li>\nArizona State University<\/li>\n<li>\nArmaGen<\/li>\n<li>\nArray Biopharma<\/li>\n<li>\nArteaus Therapeutics<\/li>\n<li>\nArtelo Biosciences<\/li>\n<li>\nArterys<\/li>\n<li>\nArvelle Therapeutics<\/li>\n<li>\nAsahi Kasei<\/li>\n<li>\nAsana Biosciences<\/li>\n<li>\nAscend Therapeutics<\/li>\n<li>\nAsceneuron<\/li>\n<li>\nAskAt<\/li>\n<li>\nAsklepios Biopharmaceutical<\/li>\n<li>\nAspen Holding<\/li>\n<li>\nAssertio Therapeutics<\/li>\n<li>\nAssociation for Frontotemporal Degeneration<\/li>\n<li>\nAstellas Pharma<\/li>\n<li>\nAstellas Pharma Europe<\/li>\n<li>\nAsterias Biotherapeutics<\/li>\n<li>\nAstex Pharmaceuticals<\/li>\n<li>\nAstraZeneca<\/li>\n<li>\nATAI Life Sciences<\/li>\n<li>\nAtara Biotherapeutics<\/li>\n<li>\nAtaxion<\/li>\n<li>\nAthersys<\/li>\n<li>\nAtnahs Pharma<\/li>\n<li>\nAucta Pharmaceuticals<\/li>\n<li>\nAural Analytics<\/li>\n<li>\nAurora Cannabis<\/li>\n<li>\nAustin Health<\/li>\n<li>\nAustralian Imaging<\/li>\n<li>\nBiomarker &amp; Lifestyle Flagship Study of Ageing (AIBL)<\/li>\n<li>\nAustralian Research Council<\/li>\n<li>\nAvanos Medical<\/li>\n<li>\nAvella<\/li>\n<li>\nAvenue Therapeutics<\/li>\n<li>\nAveXis<\/li>\n<li>\nAXIM Biotechnologies<\/li>\n<li>\nAxoSim<\/li>\n<li>\nAxovant Sciences<\/li>\n<li>\nAxsome Therapeutics<\/li>\n<li>\nAxxess Pharma<\/li>\n<li>\nAziyo Biologics<\/li>\n<li>\nBachem<\/li>\n<li>\nBachmann-Strauss Dystonia &amp; Parkinson Foundation<\/li>\n<li>\nBaergic Bio<\/li>\n<li>\nBain Capital<\/li>\n<li>\nBanyan Biomarkers<\/li>\n<li>\nBaudry Laboratory<\/li>\n<li>\nBaxter International<\/li>\n<li>\nBayer<\/li>\n<li>\nBaylor College<\/li>\n<li>\nBaylor College of Medicine<\/li>\n<li>\nB Braun<\/li>\n<li>\nBD Consultancy<\/li>\n<li>\nBecton Dickinson<\/li>\n<li>\nBeijing Leadman Biochemistry<\/li>\n<li>\nBen-Gurion University<\/li>\n<li>\nBenevolentAI<\/li>\n<li>\nBenvenue Medical<\/li>\n<li>\nBerg<\/li>\n<li>\nBest Choice<\/li>\n<li>\nBeyond Batten Disease Foundation<\/li>\n<li>\nBhang<\/li>\n<li>\nBial<\/li>\n<li>\nBIA Separations<\/li>\n<li>\nBiedermann Motech<\/li>\n<li>\nBio-Techne<\/li>\n<li>\nBioArctic Neuroscience<\/li>\n<li>\nbiOasis Technologies<\/li>\n<li>\nBioAxone Therapeutic<\/li>\n<li>\nBiocodex<\/li>\n<li>\nBIOCORP<\/li>\n<li>\nBioCrossroads<\/li>\n<li>\nBiodextris<\/li>\n<li>\nBiodirection<\/li>\n<li>\nBiofourmis<\/li>\n<li>\nBiogen<\/li>\n<li>\nBiohaven Pharmaceutical Holding<\/li>\n<li>\nBiohealth Innovation<\/li>\n<li>\nBioinn Molecular Diagnosis<\/li>\n<li>\nBioLamina<\/li>\n<li>\nBiolineRX<\/li>\n<li>\nBioMarin Pharmaceutical<\/li>\n<li>\nBiomedical Advanced Research and Development Authority<\/li>\n<li>\nBioMedical Research<\/li>\n<li>\nBioMed X Innovation Center<\/li>\n<li>\nBioMotiv<\/li>\n<li>\nBionik Laboratories<\/li>\n<li>\nBionomics<\/li>\n<li>\nBionure<\/li>\n<li>\nBiopharmaceuticals Australia<\/li>\n<li>\nBioQ Pharma<\/li>\n<li>\nBioscience Pharma Partners<\/li>\n<li>\nBioSpring<\/li>\n<li>\nBioSyent Pharma<\/li>\n<li>\nBioTie Therapies<\/li>\n<li>\nBiotoscana Farma<\/li>\n<li>\nBiscayne Neurotherapeutics<\/li>\n<li>\nBlackfynn<\/li>\n<li>\nBlackrock Microsystems<\/li>\n<li>\nBlackrock NeuroMed<\/li>\n<li>\nBlackThorn Therapeutics<\/li>\n<li>\nBlinktbi<\/li>\n<li>\nBloom Science<\/li>\n<li>\nBlueRock Therapeutics<\/li>\n<li>\nBoehringer Ingelheim<\/li>\n<li>\nBoston Scientific<\/li>\n<li>\nBoston University<\/li>\n<li>\nBoston University School of Medicine<\/li>\n<li>\nBpifrance<\/li>\n<li>\nBracket<\/li>\n<li>\nBraeburn Pharmaceuticals<\/li>\n<li>\nBrain and Spine Institute<\/li>\n<li>\nBRAINBox Solutions<\/li>\n<li>\nBRAIN Initiative<\/li>\n<li>\nBrainLAB<\/li>\n<li>\nBrainScope<\/li>\n<li>\nBrainStorm Cell Therapeutics<\/li>\n<li>\nBrainsway<\/li>\n<li>\nBrain Treatment Center San Diego<\/li>\n<li>\nBrammer Bio<\/li>\n<li>\nBreathe Active<\/li>\n<li>\nBridgeBio Pharma<\/li>\n<li>\nBrigham and Women&#8217;s Hospital<\/li>\n<li>\nBristol-Myers Squibb<\/li>\n<li>\nBroad Institute<\/li>\n<li>\nBrooks Automation<\/li>\n<li>\nBrown University<\/li>\n<li>\nBruker<\/li>\n<li>\nC2N Diagnostics<\/li>\n<li>\nC4 Therapeutics<\/li>\n<li>\nC4X Discovery<\/li>\n<li>\nCactus Semiconductor<\/li>\n<li>\nCadence Biomedical<\/li>\n<li>\nCadence Pharmaceuticals<\/li>\n<li>\nCadila Pharmaceuticals<\/li>\n<li>\nCal-BRAIN<\/li>\n<li>\nCalico<\/li>\n<li>\nCalifornia Institute for Biomedical Research<\/li>\n<li>\nCalifornia Institute for Regenerative Medicine<\/li>\n<li>\nCalifornia Institute of Technology<\/li>\n<li>\nCalmare Therapeutics<\/li>\n<li>\nCalox de Costa Rica<\/li>\n<li>\nCamargo Pharmaceutical Services<\/li>\n<li>\nCamarus<\/li>\n<li>\nCambridge Cognition<\/li>\n<li>\nCambridge Commodities<\/li>\n<li>\nCamino Partnership<\/li>\n<li>\nCAMP4 Therapeutics<\/li>\n<li>\nCanadian Institutes of Health Research<\/li>\n<li>\nCanadian Physiotherapy Association<\/li>\n<li>\nCanbex Therapeutics<\/li>\n<li>\nCanigma<\/li>\n<li>\nCannaKids<\/li>\n<li>\nCannaRoyalty<\/li>\n<li>\nCanntab Therapeutics<\/li>\n<li>\nCannvalate<\/li>\n<li>\nCanon Virginia<\/li>\n<li>\nCanopy Growth<\/li>\n<li>\nCantabio Pharmaceuticals<\/li>\n<li>\nCapnia<\/li>\n<li>\nCaprion Proteomics<\/li>\n<li>\nCaputron Medical<\/li>\n<li>\nCaraway Therapeutics<\/li>\n<li>\nCardiff University<\/li>\n<li>\nCarestream Health<\/li>\n<li>\nCaretta Therapeutics<\/li>\n<li>\nCarl Zeiss<\/li>\n<li>\nCarmot Therapeutics<\/li>\n<li>\nCarna BioSciences<\/li>\n<li>\nCarnegie Mellon University<\/li>\n<li>\nCarrum Health<\/li>\n<li>\nCase Western Reserve University<\/li>\n<li>\nCasma Therapeutics<\/li>\n<li>\nCAS Medical Systems<\/li>\n<li>\nCastle Creek Pharmaceuticals<\/li>\n<li>\nCatalent<\/li>\n<li>\nCatalyst Pharmaceutical Partners<\/li>\n<li>\nCavoGene LifeSciences<\/li>\n<li>\nCBD Solutions<\/li>\n<li>\nCedars-Sinai Medical Center<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/2229053\/global_central_nervous_system_partnering?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wzj5g7&amp;utm_campaign=1839043+-+Global+Central+Nervous+System+Partnering+2023%3A+Information+on+Every+Deal+Since+2016&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/sjofb7<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x70;r&#x65;s&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;c&#x68;a&#x6e;d&#109;&#x61;&#114;&#x6b;&#101;&#x74;&#115;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#115;&#115;&#64;r&#x65;&#x73;&#x65;&#x61;&#114;&#99;ha&#x6e;&#x64;&#x6d;&#97;&#114;&#107;et&#x73;&#x2e;&#x63;&#111;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2016. Trends in central nervous system partnering deals &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55719","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2016. Trends in central nervous system partnering deals ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T09:04:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-04-12T09:04:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/\"},\"wordCount\":1625,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005439\\\/en\\\/1761858\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/\",\"name\":\"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005439\\\/en\\\/1761858\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-04-12T09:04:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005439\\\/en\\\/1761858\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230412005439\\\/en\\\/1761858\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world&#8217;s pharmaceutical and biotechnology companies since 2016. Trends in central nervous system partnering deals ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-12T09:04:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 &#8211; ResearchAndMarkets.com","datePublished":"2023-04-12T09:04:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/"},"wordCount":1625,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/","name":"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg","datePublished":"2023-04-12T09:04:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230412005439\/en\/1761858\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-central-nervous-system-partnering-2023-information-on-every-deal-since-2016-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Central Nervous System Partnering 2023: Information on Every Deal Since 2016 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55719"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55719\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}